Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications

Background: Unintentional ingestion of selective serotonin reuptake inhibitor (SSRI) medications is common amongst children <6 years of age. Current evidence-based management guidelines are based on a low incidence of significant medical outcomes in these children.Objective: To describe and compare outcomes of pediatric exposures to vilazodone with other SSRIs.Methods: A retrospective observational case series analysis of both single and...